Prima Biomed Ltd
ASX:PRR ISIN:AU000000PRR9
News
Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.
Sino Gas & Energy Holdings Limited (ASX:SEH), an Australian company developing unconventional gas assets within the Ordos Basin, Shanxi Province China, is pleased to advise that it has signed an agreement to raise up to A$29.4 million in new funds from SpringTree Special Opportunities Fund, LP, a New York-based institutional investor, over the next two years.
Australian Market Report of February 21, 2011 includes: Prima BioMed Limited (ASX:PRR) will commence the Phrase III clinical trial for what could be the world's first ovarian cancer immunotherapy vaccine; Redstone Resources Limited (ASX:RDS) announced further high grade copper results at the Tollu copper project in Western Australia; Western Desert Resources Limited (ASX:WDR) reported more high-grade iron ore results at Roper Bar Iron Ore Project in the Northern Territory; Canyon Resources Limited (ASX:CAY) updated on accelerated drilling program in Burkina Faso.
Australian cancer treatment development company Prima Biomed (Prima, the Company) (ASX: PRR) is pleased to provide the following update and advances in its cancer treatment technologies and programs.
PRIMA BIOMED LTD (ASX: PRR) - Interim Results - Clinical Trial for Ovarian Cancer Drug; Mr Eugene Kopp, Executive Chairman; Boardroomradio is pleased to announce that PRIMA BIOMED LTD (ASX: PRR) has p
PRIMA BIOMED LTD (ASX: PRR) - Interim Results - Clinical Trial for Ovarian Cancer Drug; Dr George Mihaly, Chair of Scientific Advisory Panel; Boardroomradio is pleased to announce that PRIMA BIOMED LT
140,310 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 22) (Last 30 Days: 62) (Since Published: 15158)